Consumer prices rose 0.4 percent in December, with the Consumer Price Index up 2.9 percent from a year earlier, driven by food prices. Core inflation slowed slightly to 3.2 percent, but overall progress has stalled, leading to concerns at the Federal Reserve and a likelihood of interest rates remaining steady in the near future.
Full Article
Bicycle (BCYC) Q2 Revenue Falls 69%
Bicycle Therapeutics Plc (NASDAQ:BCYC) reported Q2 2025 GAAP revenue of $2.9 million, significantly below the $9.43 million analyst estimate, while net loss per share widened to $(1.14), surpassing the $(0.95) forecast. Despite increased clinical investment and operational spending aimed at advancing its pipeline of precision-guided therapeutics using its proprietary Bicycle molecule platform, the company emphasized the need for operational discipline and clear milestones ahead. Want More Context? 🔎
Read more